These biotechs may surge on drug news: Expert By: CNBC.com News May 29, 2015 at 15:31 PM EDT Incyte stands to benefit from unveiling data on its cancer treatments at a conference in the coming days, a biotech analyst said. Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Incyte Corp Merck & Co